New Guidelines on Testosterone

Updated information for treatment of low levels

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

THURSDAY, Dec. 26, 2002 (HealthDayNews) -- Updated medical guidelines for the treatment and evaluation of low testosterone in men have been announced by the American Association of Clinical Endocrinologists (AACE).

The new guidelines, which appear in the November/December issue of Endocrine Practice, discuss symptoms of low testosterone and the importance of correct diagnosis and treatment by physicians.

Low testosterone levels can be caused by a variety of factors including conditions associated with the testes, pituitary gland or hypothalamus gland, or by a genetic disorder. Low testosterone levels may also be age-related.

Low testosterone levels can cause decreased libido, impotence, a decrease in muscle mass, fatigue and decreased bone density in conjunction with osteoporosis.

Research indicates that testosterone replacement therapy (TRT) is often effective in treating such symptoms.

The AACE says TRT should be administered only under medical supervision to identify early indications of possible adverse effects. Men with known prostate cancer should not receive TRT and postrate specific antigen (PSA) levels should be carefully monitored in men receiving TRT, the AACE says.

More information

Here's where you can learn more about low testosterone.

SOURCE: American Association of Clinical Endocrinologists, news release, December 2002

--

Last Updated:

Related Articles